Phathom Pharmaceuticals (PHAT) Capital Expenditures (QoQ) (2020 - 2025)
Phathom Pharmaceuticals (PHAT) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Phathom Pharmaceuticals |
895.99 Mn |
712.23 Mn |
46.31 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
378.13% |
| Sep 30, 2025 |
-165.98% |
| Jun 30, 2025 |
438.89% |
| Mar 31, 2025 |
260.00% |
| Dec 31, 2024 |
-95.83% |
| Sep 30, 2024 |
3,900.00% |
| Jun 30, 2024 |
-57.14% |
| Mar 31, 2024 |
100.61% |
| Dec 31, 2023 |
-221.51% |
| Sep 30, 2023 |
15,550.00% |
| Jun 30, 2023 |
-97.20% |
| Mar 31, 2023 |
143.58% |
| Dec 31, 2022 |
-180.10% |
| Sep 30, 2022 |
689.42% |
| Jun 30, 2022 |
-186.67% |
| Mar 31, 2022 |
-62.38% |
| Dec 31, 2021 |
255.61% |
| Sep 30, 2021 |
-206.22% |
| Jun 30, 2021 |
819.05% |
| Mar 31, 2021 |
-97.90% |
